However, we also demonstrated that ACTL6A-mediated glioma cell proliferation, migration, and invasion could be partially reversed by YAP/TAZ knockdown or ectopic expression, indicating that YAP/TAZ is not a unique downstream effector of ACTL6A in glioma cells. The gene discussed is ACTL6A; the disease is central nervous system cancer.